Guidance for Sucampo Pharmaceuticals (SCMP)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2017 | $1.10 – $1.15 | $1.01 | $250.00M – 255.00M | $234.50M |  Raised |
Details |
| Q3 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q2 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q1 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| 2016 | $1.20 – $1.25 | $1.04 | $220.00M – 225.00M | $205.70M | Raised |
Details |
| 2016 | $0.97 – $1.07 | $1.05 | $195.00M – 205.00M | $202.30M | = Maintained | Details |
| 2015 | $0.65 – $0.75 | $0.62 | N/A | N/A | = Maintained | Details |
| 2014 | $0.08 – $0.13 | $0.18 | N/A | N/A | = Maintained | Details |
